A specialist doctor called a haematologist will arrange for you to have some tests including a bone marrow sample.
If you're struggling to find what you need, call our Support line on 0808 808 0000 (7 days a week, 8am-8pm)More ways to contact us
The cause of ALL is not known, but research is going on all the time to find out more about it. Like other cancers, ALL isn’t infectious and can’t be passed on to other people.
There are a number of factors that may increase a person’s risk of developing ALL. Having a particular risk factor doesn’t mean you will definitely get ALL. And people without any known risk factors can still develop it. The known risk factors of ALL are:
Exposure to very high radiation levels increases the risk of developing ALL. However, very few people in the UK will be exposed to radiation levels high enough to increase their risk. For example, these might be the high levels of radiation following a nuclear accident.
In recent years there has been publicity about a possible increase in risk of leukaemia in children living close to nuclear power plants. A large study found that there is very little evidence of an increase in risk.
Research has shown that a person’s risk of developing ALL is not significantly increased by exposure to radon gas. Radon is a naturally occurring gas that can pass from the soil into the foundations of some buildings in parts of the UK.
ALL is not caused by an inherited faulty gene, so members of your family don’t have an increased risk of developing ALL just because you have it. However, people with certain genetic disorders, including Down’s syndrome and Fanconi’s anaemia, are known to have a higher risk of developing leukaemia.
In very rare cases, leukaemia may occur in people who have been exposed to chemicals used in industry, such as benzene and other solvents.
It is thought that ALL develops because of changes to a certain type of immature blood cell. What causes the changes is not fully understood, but infection may be involved. However, no specific infections have been found to cause leukaemia.
Order or download our free booklet about acute lymphoblastic leukaemia (ALL). It covers symptoms, diagnosis, possible treatments, and practical issues.
Worrying about cancer can have a big impact on your feelings. Read our advice to help you cope with your emotions.
If you're deciding which charity to support with your fundraising, talk to us. We want to be there for everyone affected by cancer, and we need your help.
What's happening near you? Find out about support groups, where to get information and how to get involved with Macmillan where you are.
We rely on a number of sources to gather evidence for our information. If you’d like further information on the sources we use, please feel free to contact us on: email@example.com
All our information is reviewed by cancer or other relevant professionals to ensure that it’s accurate and reflects the best evidence available. We thank all those people who have provided expert review for the information on this page.
Our information is also reviewed by people affected by cancer to ensure it is as relevant and accessible as possible. Thank you to all those people who reviewed what you're reading and have helped our information to develop.
You could help us too when you join our Cancer Voices Network – find out more at: http://www.macmillan.org.uk/cancervoices
Need to talk? Call us free* 0808 808 00 00 7 days a week, 8am-8pm
© Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007
We make every effort to ensure that the information we provide is accurate and up-to-date but it should not be relied upon as a substitute for specialist professional advice tailored to your situation. So far as is permitted by law, Macmillan does not accept liability in relation to the use of any information contained in this publication or third party information or websites included or referred to in it.